This research study will assess whether AAB-001 is safe, well tolerated and effective for use in patients with Alzheimer's Disease. AAB-001 is a new drug that is not available outside this study. AAB-001 is an antibody (a type of protein usually produced by white blood cells to destroy other substances in the body). In Alzheimer's disease a protein called amyloid gathers in the brain and is thought to cause symptoms like memory loss and confusion. It is hoped that AAB-001 will attach to the amyloid protein in your brain and help your body to remove it.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Pharmacology Research Institute
Los Alamitos, California, United States
Pharmacology Research Institute
Northridge, California, United States
Safety assessments
Blood levels of administered study drug
Cognitive and functional assessments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.